ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,387Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 1269

$636K Total Retail Price of All Prescriptions

Rank: 73 out of 1269

497 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 11,520 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 693 503 1 1
ATENOLOL 685 555 2 14
PRAVASTATIN SODIUM 538 456 3 11
FUROSEMIDE 514 399 4 5
AMLODIPINE BESYLATE 427 410 5 2
LEVOTHYROXINE SODIUM 367 344 6 4
SIMVASTATIN 332 278 7 3
HYDROCHLOROTHIAZIDE 298 263 8 10
OMEPRAZOLE 292 212 9 8
ATORVASTATIN CALCIUM 273 215 10 7
METOPROLOL TARTRATE 264 222 11 6
CITALOPRAM HBR 239 189 12 21
METOPROLOL SUCCINATE 232 226 13 13
ALENDRONATE SODIUM 223 176 14 28
TRAMADOL HCL 203 168 15 16
GLIPIZIDE 201 186 16 37
POTASSIUM CHLORIDE 185 162 17 26
METFORMIN HCL 182 124 18 9
DONEPEZIL HCL 165 155 19 22
TAMSULOSIN HCL 152 134 20 31
ALLOPURINOL 150 102 21 49
GABAPENTIN 146 91 22 17
ISOSORBIDE MONONITRATE ER 137 114 23 63
PANTOPRAZOLE SODIUM 136 101 24 18
DIVALPROEX SODIUM 125 105 25 54
RANITIDINE HCL 120 92 26 27
NEXIUM 119 78 27 41
SERTRALINE HCL 118 62 28 23
DIGOXIN 113 50 29 62
WARFARIN SODIUM 109 87 30 12
GLIMEPIRIDE 109 104 30 57
ZOLPIDEM TARTRATE 107 86 32 19
CRESTOR 106 80 33 25
IBUPROFEN 106 75 33 73
LOSARTAN POTASSIUM 101 81 35 15
MIRTAZAPINE 100 100 36 24
ATENOLOL-CHLORTHALIDONE 97 85 37 163
AZITHROMYCIN 94 67 38 42
ADVAIR DISKUS 91 84 39 46
QUINAPRIL HCL 88 84 40 167
TERAZOSIN HCL 86 75 41 111
CARVEDILOL 82 50 42 29
CYMBALTA 80 44 43 70
RISPERIDONE 78 30 44 43
FLUTICASONE PROPIONATE 77 66 45 40
LANSOPRAZOLE 73 61 46 120
PREDNISONE 72 59 47 45
FENTANYL 71 70 S2 48 105
ZETIA 68 61 49 99
ESCITALOPRAM OXALATE 67 53 50 58
TRICOR 66 29 51 152
DIOVAN 65 53 52 35
TRAZODONE HCL 64 35 53 36
FELODIPINE ER 62 62 54 223
CIPROFLOXACIN HCL 62 50 54 66
OXYBUTYNIN CHLORIDE 61 61 56 128
LIDODERM 58 58 57 56
QUETIAPINE FUMARATE 58 49 57 53
PROAIR HFA 57 49 59 61
CYCLOBENZAPRINE HCL 57 18 R 59 93
ROPINIROLE HCL 56 44 61 151
POLYETHYLENE GLYCOL 3350 56 40 61 50
NAMENDA 56 56 61 38
CLONIDINE HCL 55 34 64 51
CLOPIDOGREL 54 50 65 32
HYDROCODONE-ACETAMINOPHEN 53 51 S3 66 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 39 67 33
AMPICILLIN TRIHYDRATE 50 39 68 394
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.